Publication Archive - Page 4 sur 18

Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024

Laniece Delaunay C, Melo A, Maurel M, Mazagatos C, Goerlitz L, O’Donnell J, Oroszi B, Sève N, Rodrigues AP, Martínez-Baz I, Meijer A, Mlinarić I, Latorre-Margalef N, Lazăr M, Pérez-Gimeno G, Dürrwald R, Bennett C, Túri G, Rameix-Welti MA, Guiomar R, Castilla J, Hooiveld M, Kurečić Filipović S, Samuelsson Hagey T, Dijkstra F, Borges V, Ramos Marín V, Bacci S, Kaczmarek M, Kissling E; European primary care VE group.

2024 Jun 4:S0264-410X(24)00644-3. doi: 10.1016/j.vaccine.2024.05.067. Epub ahead of print. PMID: 38839521.

Available here

BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study

Sanjin Musa, Lore Merdrignac, Sinisa Skocibusic, Rozalija Nedic, Seila Cilovic-Lagarija, Esther Kissling

Received 31 January 2024, Revised 30 March 2024, Accepted 14 April 2024, Available online 21 April 2024, Version of Record 17 May 2024.

Available here

PANDEM-Source, a tool to collect or generate surveillance indicators for pandemic management: a use case with COVID-19 data

Orchard F, Clain C, Madie W, Hayes JS, Connolly MA, Sevin E, Sentís A.

Front Public Health. 2024 Mar 20;12:1295117. doi: 10.3389/fpubh.2024.1295117. PMID: 38572005; PMCID: PMC10989069.

Available here

COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022

Lanièce Delaunay Charlotte, Martínez-Baz Iván, Sève Noémie, Domegan Lisa, Mazagatos Clara, Buda Silke, Meijer Adam, Kislaya Irina, Pascu Catalina, Carnahan AnnaSara, Oroszi Beatrix, Ilić Maja, Maurel Marine, Melo Aryse, Sandonis Martín Virginia, Trobajo-Sanmartín Camino, Enouf Vincent, McKenna Adele, Pérez-Gimeno Gloria, Goerlitz Luise, de Lange Marit, Rodrigues Ana Paula, Lazar Mihaela, Latorre-Margalef Neus, Túri Gergő, Castilla Jesús, Falchi Alessandra, Bennett Charlene, Gallardo Virtudes, Dürrwald Ralf, Eggink Dirk, Guiomar Raquel, Popescu Rodica, Riess Maximilian, Horváth Judit Krisztina, Casado Itziar, García Mª del Carmen, Hooiveld Mariëtte, Machado Ausenda, Bacci Sabrina, Kaczmarek Marlena, Kissling Esther, on behalf of the European Primary Care Vaccine Effectiveness Group.

Euro Surveill. 2024;29(13):pii=2300403.

Available here

Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020

Debin M, Launay T, Rossignol L, Ait El Belghiti F, Brisse S, Guillot S, Guiso N, Levy-Bruhl D, Merdrignac L, Toubiana J, Blanchon T, Hanslik T.

Euro Surveill. 2022;27(17):pii=2100515.

Available here

Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 – December 2019

Lore Merdrignac, Fatima Aït El Belghiti, Elisabetta Pandolfi, Lesly Acosta, Kateřina Fabiánová, Adele Habington, Manuel García Cenoz, Håkon Bøås, Julie Toubiana, Alberto E. Tozzi, Iolanda Jordan, Jana Zavadilová, Niam O’Sullivan, Ana Navascués, Elmira Flem, Ilena Croci, Mireia Jané, Pavla Křížová, Suzanne Cotter, Leticia Fernandino, Terese Bekkevold, Carmen Muñoz-Almagro, Sabrina Bacci, Piotr Kramarz, Esther Kissling, Camelia Savulescu

Vaccine, 2024, ISSN 0264-410X

Available here

Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network

Angela M. C. Rose, Francisco Pozo, Iván Martínez-Baz, Clara Mazagatos, Nathalie Bossuyt, John Paul Cauchi, Goranka Petrović, Isabela I. Loghin, Roberta Vaikutyte, Silke Buda, Ausenda Machado, Róisín Duffy, Beatrix Oroszi, Jennifer Howard, Aitziber Echeverria, Cristina Andreu, Cyril Barbezange, Aušra Džiugytė, Diana Nonković, Corneliu-Petru Popescu, Fausta Majauskaite, Kristin Tolksdorf, Verónica Gomez, Lisa Domegan, Judit Krisztina Horváth, Jesús Castilla, Miriam García, Thomas Demuyser, Maria-Louise Borg, Irena Tabain, Mihaela Lazar, Ieva Kubiliute, Ralf Dürrwald, Raquel Guiomar, Joan O’Donnell, Katalin Kristóf, Nathalie Nicolay, Sabrina Bacci, Esther Kissling, VEBIS SARI VE network team

Influenza Other Respi Viruses. 2024; 18(2):e13255. doi:10.1111/irv.13255

Available here

Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024

Maurel Marine, Howard Jennifer, Kissling Esther, Pozo Francisco, Pérez-Gimeno Gloria, Buda Silke, Sève Noémie, McKenna Adele, Meijer Adam, Rodrigues Ana Paula, Martínez-Baz Iván, Mlinarić Ivan, Latorre-Margalef Neus, Túri Gergő, Lazăr Mihaela, Mazagatos Clara, Echeverria Aitziber, Abela Stephen, Bourgeois Marc, Machado Ausenda, Dürrwald Ralf, Petrović Goranka, Oroszi Beatrix, Jancoriene Ligita, Marin Alexandru, Husa Petr, Duffy Roisin, Dijkstra Frederika, Gallardo García Virtudes, Goerlitz Luise, Enouf Vincent, Bennett Charlene, Hooiveld Mariëtte, Guiomar Raquel, Trobajo-Sanmartín Camino, Višekruna Vučina Vesna, Samuelsson Hagey Tove, Lameiras Azevedo Ana Sofía, Castilla Jesús, Xuereb Gerd, Delaere Bénédicte, Gómez Verónica, Tolksdorf Kristin, Bacci Sabrina, Nicolay Nathalie, Kaczmarek Marlena, Rose Angela MC, on behalf of the European IVE group.

Euro Surveill. 2024;29(8):pii=2400089.

Available here

Protocol for a COVID-19 vaccine effectiveness study using health data registries, v.2.0

Susana Monge Corella, Mario Fontán Vela (Instituto de Salud Carlos III, Spain), Irina Kislaya, Baltazar Nunes,
Ausenda Machado, Patricia Soares and Constantino Caetano (Instituto Nacional de Saúde, Portugal), Cristina
Buguri, Itziar Casado, Jesús Castilla, Iván Martínez-Baz (Instituto de Salud Pública y Laboral de Navarra), HanneDorthe Emborg, Katrin Finderup, Christian Holm Hansen, Bolette Søborg, Palle Valentiner-Branth (Statens Serum
Institut, Denmark), Jostein Starrfelt, Hinta Meijerink, Anja Bråthen Kristoffersen (Norwegian Institute of Public
Health), Joris van Loenhout, Toon Braeye, Izaak Van Evercooren, Pierre Hubin (Sciensano, Belgium), Brechje de
Gier, Susan Hahné (Dutch National Institute for Public Health and the Environment – RIVM-, the Netherlands), Ala’a
AlKerwi, Susanne Schmitz (Ministry of Health, Directorate of Health, Service epidemiology and statistics,
Luxembourg), Chiara Sacco, Alberto Mateo Urdiales, and Massimo Fabiani (Istituto Superiore di Sanità, Italy),
Anthony Nardone, Alexis Sentís, Esther Kissling, James Humphreys, Marta Valenciano (Epiconcept, France).

European Centre for Disease Prevention and Control. Stockholm: ECDC; 2024

Available here

Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection, laboratory-confirmed with SARS-CoV-2 or with seasonal influenza – Version 3.0

Liliana Antunes, Jenny Howard, Esther Kissling, Ruoran Li, Alain Moren, Anthony Nardone, Angie Rose, Marta Valenciano

ECDC - Version 3.0

Available here

Publication

Référencement Centrales d'achats

Hébergement de données de santé

Engagement et éthique